XML 19 R7.htm IDEA: XBRL DOCUMENT v3.24.2.u1
CONDENSED CONSOLIDATED STATEMENT OF SHAREHOLDERS' EQUITY (unaudited) - USD ($)
$ in Thousands
Total
Common Stock
Retained Earnings
Accumulated Other Comprehensive Loss
Beginning balance (in shares) at Dec. 31, 2022   7,149,884    
Beginning balance at Dec. 31, 2022 $ 211,154 $ 1,743 $ 224,392 $ (14,981)
Increase (Decrease) in Shareholders' Equity        
Net income 8,918   8,918  
Foreign currency translation adjustment 1,052     1,052
Share-based compensation expense 940 $ 940    
Restricted shares vesting (in shares)   45,544    
Redemption of vested employee restricted shares for tax withholding (in shares)   (16,614)    
Redemption of vested employee restricted shares for tax withholding (1,873) $ (1,873)    
Shares repurchased (in shares)   (180,881)    
Shares repurchased (20,577) $ (810) (19,767)  
Accrued excise tax on shares repurchased (173)   (173)  
Accrued dividends on unvested shares 45   45  
Cash dividends paid (per share) (2,702)   (2,702)  
Ending balance (in shares) at Apr. 01, 2023   6,997,933    
Ending balance at Apr. 01, 2023 $ 196,784 $ 0 210,713 (13,929)
Increase (Decrease) in Shareholders' Equity        
Common share quarterly cash dividend declared (in dollars per share) $ 0.36      
Beginning balance (in shares) at Dec. 31, 2022   7,149,884    
Beginning balance at Dec. 31, 2022 $ 211,154 $ 1,743 224,392 (14,981)
Increase (Decrease) in Shareholders' Equity        
Net income 18,426      
Foreign currency translation adjustment 2,126      
Ending balance (in shares) at Jul. 01, 2023   6,969,236    
Ending balance at Jul. 01, 2023 202,786 $ 468 215,173 (12,855)
Beginning balance (in shares) at Apr. 01, 2023   6,997,933    
Beginning balance at Apr. 01, 2023 196,784 $ 0 210,713 (13,929)
Increase (Decrease) in Shareholders' Equity        
Net income 9,508   9,508  
Foreign currency translation adjustment 1,074     1,074
Share-based compensation expense 1,158 $ 1,158    
Restricted shares vesting (in shares)   3,630    
Redemption of vested employee restricted shares for tax withholding (in shares)   (1,237)    
Redemption of vested employee restricted shares for tax withholding (136) $ (136)    
Shares repurchased (in shares)   (31,090)    
Shares repurchased (3,000) $ (554) (2,446)  
Accrued excise tax on shares repurchased (27)   (27)  
Accrued dividends on unvested shares (47)   (47)  
Cash dividends paid (per share) (2,528)   (2,528)  
Ending balance (in shares) at Jul. 01, 2023   6,969,236    
Ending balance at Jul. 01, 2023 $ 202,786 $ 468 215,173 (12,855)
Increase (Decrease) in Shareholders' Equity        
Common share quarterly cash dividend declared (in dollars per share) $ 0.36      
Beginning balance (in shares) at Dec. 30, 2023 6,934,265 6,934,265    
Beginning balance at Dec. 30, 2023 $ 212,101 $ 0 224,283 (12,182)
Increase (Decrease) in Shareholders' Equity        
Net income 13,691   13,691  
Foreign currency translation adjustment (1,105)     (1,105)
Share-based compensation expense 1,039 $ 1,039    
Restricted shares vesting (in shares)   33,441    
Redemption of vested employee restricted shares for tax withholding (in shares)   (12,526)    
Redemption of vested employee restricted shares for tax withholding (1,631) $ (1,631)    
Shares repurchased (in shares)   (65,882)    
Shares repurchased (9,242) $ 592 (9,834)  
Accrued excise tax on shares repurchased (65)   (65)  
Accrued dividends on unvested shares 77   77  
Cash dividends paid (per share) (3,075)   (3,075)  
Ending balance (in shares) at Mar. 30, 2024   6,889,298    
Ending balance at Mar. 30, 2024 $ 211,790 $ 0 225,077 (13,287)
Increase (Decrease) in Shareholders' Equity        
Common share quarterly cash dividend declared (in dollars per share) $ 0.42      
Beginning balance (in shares) at Dec. 30, 2023 6,934,265 6,934,265    
Beginning balance at Dec. 30, 2023 $ 212,101 $ 0 224,283 (12,182)
Increase (Decrease) in Shareholders' Equity        
Net income 20,229      
Foreign currency translation adjustment $ (1,420)      
Ending balance (in shares) at Jun. 29, 2024 6,752,604 6,752,604    
Ending balance at Jun. 29, 2024 $ 191,749 $ 0 205,351 (13,602)
Beginning balance (in shares) at Mar. 30, 2024   6,889,298    
Beginning balance at Mar. 30, 2024 211,790 $ 0 225,077 (13,287)
Increase (Decrease) in Shareholders' Equity        
Net income 6,538   6,538  
Foreign currency translation adjustment (315)     (315)
Share-based compensation expense 1,357 $ 1,357    
Restricted shares vesting (in shares)   6,143    
Redemption of vested employee restricted shares for tax withholding (in shares)   (2,340)    
Redemption of vested employee restricted shares for tax withholding (346) $ (346)    
Shares repurchased (in shares)   (140,497)    
Shares repurchased (24,106) $ (1,011) (23,095)  
Accrued excise tax on shares repurchased (235)   (235)  
Accrued dividends on unvested shares (33)   (33)  
Cash dividends paid (per share) $ (2,901)   (2,901)  
Ending balance (in shares) at Jun. 29, 2024 6,752,604 6,752,604    
Ending balance at Jun. 29, 2024 $ 191,749 $ 0 $ 205,351 $ (13,602)
Increase (Decrease) in Shareholders' Equity        
Common share quarterly cash dividend declared (in dollars per share) $ 0.42